Filing Details
- Accession Number:
- 0001140361-17-023684
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-02 20:26:49
- Reporting Period:
- 2017-06-01
- Filing Date:
- 2017-06-02
- Accepted Time:
- 2017-06-02 20:26:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1001233 | Sangamo Therapeutics Inc | SGMO | Biological Products, (No Disgnostic Substances) (2836) | 680359556 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1691262 | Iii A. Curt Herberts | 501 Canal Blvd Point Richmond Tech Cntr. Richmond CA 94804 | Senior Vp & Cbo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-06-01 | 2,000 | $6.80 | 35,345 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017.
- Includes 3,333 and 12,500 shares subject to restricted stock units (RSUs) granted on December 11, 2014 and December 8, 2015, respectively, that will be issued as such units vest in accordance with their terms.